Matrix stiffness modulates androgen response genes and chromatin state in prostate cancer
NAR Cancer · 15.01.2025 · 7 (1)
DOI: 10.1093/narcan/zcaf010 ↗Kurz gefasst
Fachartikel in der Zeitschrift NAR Cancer, online erschienen am 20.03.2025. Verfasst von Roosa Kaarijärvi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedicine, University of Eastern Finland, 70210, Kuopio, Finland. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Chromatin, Extracellular Matrix, Receptors, Androgen. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Council of Finland, Sigrid Jusélius Foundation, Finnish Cultural Foundation.
Abstract (Originalsprache)
The interplay between the extracellular matrix (ECM) and prostate cancer has been shown to increase ECM stiffness, correlating with more aggressive disease forms. However, the impact of ECM stiffness on the androgen receptor (AR), a key target in prostate cancer treatment, remains elusive. Here, we investigated whether matrix stiffness influences prostate cancer progression, transcriptional regulation, chromatin state, and AR function in AR-positive prostate cancer cells under varying ECM stiffness conditions. We utilized ATAC-seq (assay for transposase-accessible chromatin with sequencing) and RNA sequencing under different ECM conditions, along with the SUC2 metastatic prostate adenocarcinoma patient dataset, to investigate the role of ECM stiffness in chromatin state and androgen response genes, as well as its impact on prostate cancer progression. Results demonstrated that increased ECM stiffness elevated the expression of genes related to proliferation and differentiation. In contrast, androgen response genes were most highly induced in soft ECM conditions. Integrating chromatin accessibility with transcriptomic data revealed that androgen response genes were more transcriptionally available in soft ECM conditions. Additionally, increased ECM stiffness upregulated genes associated with low overall survival in the SUC2 dataset. Taken together, our results indicate that high expression of hard matrix stiffness genes may promote prostate cancer progression, leading to more aggressive disease forms associated with poor survival.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Biomedicine, University of Eastern Finland, 70210, Kuopio, Finland.
ORCID-Profile: Ville Paakinaho, Kirsi Ketola
Förderung
- Research Council of Finland
- Sigrid Jusélius Foundation
- Finnish Cultural Foundation
- North Savo Regional Fund
- Cancer Foundation Finland
Zitieren
APA
Kaarijärvi, R., Kaljunen, H., Niemi, O., Räsänen, M., Paakinaho, V., & Ketola, K. (2025). Matrix stiffness modulates androgen response genes and chromatin state in prostate cancer. NAR Cancer, 7(1). https://doi.org/10.1093/narcan/zcaf010
Vancouver
Kaarijärvi R, Kaljunen H, Niemi O, Räsänen M, Paakinaho V, Ketola K. Matrix stiffness modulates androgen response genes and chromatin state in prostate cancer. NAR Cancer. 2025;7(1). doi:10.1093/narcan/zcaf010
BibTeX
@article{Kaarijrvi2025,
author = {Kaarijärvi, Roosa and Kaljunen, Heidi and Niemi, Onni and Räsänen, Merja and Paakinaho, Ville and Ketola, Kirsi},
title = {Matrix stiffness modulates androgen response genes and chromatin state in prostate cancer},
journal = {NAR Cancer},
year = {2025},
volume = {7},
number = {1},
doi = {10.1093/narcan/zcaf010}
}
EUVIMED